EGFR‐mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR‐mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells
Authors
Keywords
-
Journal
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-02
DOI
10.1002/kjm2.12766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A synthetic ancestral kinesin-13 depolymerizes microtubules faster than any natural depolymerizing kinesin
- (2022) Hannah R. Belsham et al. Open Biology
- Role of tubulin acetylation in cellular functions and diseases
- (2020) Yoko Nekooki-Machida et al. Medical Molecular Morphology
- Increasing incidence of prostate cancer in Taiwan
- (2020) Po-Hung Lin et al. MEDICINE
- Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs
- (2020) Milena Rizzo BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Tubulin heterogeneity regulates functions and dynamics of microtubules and plays a role in the development of drug resistance in cancer
- (2019) Shweta Shyam Prassanawar et al. BIOCHEMICAL JOURNAL
- EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1)
- (2014) Tzyh-Chyuan Hour et al. ARCHIVES OF TOXICOLOGY
- Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
- (2014) PAUL TOREN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (Review)
- (2014) L. MAGADOUX et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Microtubules and Their Role in Cellular Stress in Cancer
- (2014) Amelia L. Parker et al. Frontiers in Oncology
- The Kinesin-2 Family Member KIF3C Regulates Microtubule Dynamics and Is Required for Axon Growth and Regeneration
- (2013) L. F. Gumy et al. JOURNAL OF NEUROSCIENCE
- Aurora B regulates spindle bipolarity in meiosis in vertebrate oocytes
- (2012) Hua Shao et al. CELL CYCLE
- Overexpression of Mitotic Centromere-Associated Kinesin Stimulates Microtubule Detachment and Confers Resistance to Paclitaxel
- (2011) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Docetaxel-based combination therapy for castration-resistant prostate cancer
- (2010) M. D. Galsky et al. ANNALS OF ONCOLOGY
- Class III -Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
- (2010) G. Ploussard et al. CANCER RESEARCH
- MEC-17 is an α-tubulin acetyltransferase
- (2010) Jyothi S. Akella et al. NATURE
- HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons
- (2010) Sigeng Chen et al. PLoS One
- Kinesin-13s in mitosis: Key players in the spatial and temporal organization of spindle microtubules
- (2010) Stephanie C. Ems-McClung et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Elongator Controls the Migration and Differentiation of Cortical Neurons through Acetylation of α-Tubulin
- (2009) Catherine Creppe et al. CELL
- Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes
- (2009) R. M. Attar et al. CLINICAL CANCER RESEARCH
- CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
- (2009) Sara A Wickström et al. EMBO JOURNAL
- Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53
- (2008) Julien Giustiniani et al. CELLULAR SIGNALLING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started